Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdaySep 15, 2026 10:30 am

Market Street Capital Inc. Sees Rising Power Demand Driving New Capital Choices for Founders

Energy is one of the sectors where the debt vs. equity decision has become especially pressing. As Market Street frames it, the tradeoff is straightforward in concept but consequential in practice. This is the kind of decision Market Street Capital's platform is built to help energy founders work through. For a growing number of middle-market energy founders, the hardest strategic decision is not what to build next but how to pay for it. Market Street Capital, a capital markets and financial advisory firm, works with established middle-market businesses navigating exactly this kind of decision. The company’s team members have spent…

Continue Reading

TuesdaySep 15, 2026 9:45 am

BOXABL Inc. (NASDAQ: BXBL) Joins Nasdaq Following SPAC Merger Approval, Bringing Factory-Built Housing Model to Public Markets

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL has begun trading on Nasdaq under the ticker symbol BXBL. The move values BOXABL at approximately $3.5 billion, with approximately 350 million shares issued at $10 per share. The company has so far raised over $230 million from 50,000+ investors. BOXABL is pursuing a technology-driven approach…

Continue Reading

TuesdaySep 15, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

VERAXA is developing antibody-based cancer therapies aimed at improving the therapeutic window of existing treatment modalities. Its proprietary BiTAC platform uses two complementary molecules that are designed to activate cytotoxic activity only when both recognize targets on the same tumor cell. The company is applying the BiTAC concept to both antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), with an emphasis on solid tumors. With ADCs and bispecific antibodies attracting substantial investment, VERAXA is operating in oncology markets where technological differentiation can have significant strategic value. VERAXA Biotech (NASDAQ: VRXA) is developing a new generation of antibody-based cancer therapies at a…

Continue Reading

MondaySep 14, 2026 10:30 am

Market Street Capital Inc. Provides Succession Expertise as a Wave of Family Businesses Prepares to Transition

Study estimates about six million small and midsize family-owned businesses will face transitions by 2035. Preparation for that transition starts with reliable numbers and informed guidance. Through its strategic planning and advisory practice and investment banking platform, Market Street Capital offers key insight, direction. Family-owned industrial businesses built over decades are approaching a reckoning: Who runs the company next, and whether that transition happens on the owner's terms or by default. Market Street Capital, a boutique capital markets and financial advisory firm, works with established middle-market businesses navigating exactly this kind of pivotal moment. The company advises founder-led and family-owned…

Continue Reading

MondaySep 14, 2026 9:45 am

Frontieras North America Inc. Links America’s Coal Reserves to Country’s Fertilizer Future

Energy is the foundation of everything the global economy runs on, from manufacturing to transportation to food production. The United States has made real progress reducing its reliance on imported ammonia, with net import reliance falling to about 5% in 2025. Frontieras North America is supporting that trend toward diversification with a technology it calls Solid Carbon Fractionation, branded FASForm(TM). American farmers depend on nitrogen fertilizer, and nitrogen fertilizer depends on energy. That bridge is why fertilizer security at its core is actually an energy story ... and problem. It is also why Frontieras North America is positioning its coal-based…

Continue Reading

MondaySep 14, 2026 9:00 am

Earth Science Tech Inc.’s (ETST) Shareholders Approve Key Proposals in Annual Meeting

Earth Science Tech held its first annual meeting of stockholders, virtually, on August 31, 2026+ The shareholders authorized the Board to pursue a reverse stock split, if deemed necessary, to help the company uplist to a national exchange like Nasdaq or NYSE During the meeting, stockholders authorized the Board’s Independent Special Committee to negotiate the retirement of the Series B Preferred Stock, which would eliminate the current dual-class voting structure The shareholders also ratified the appointment of Semple, Marchal & Cooper LLP, as an independent registered public accounting firm, re-elected seven director nominees, and authorized a new non-dilutive executive compensation…

Continue Reading

FridaySep 11, 2026 11:15 am

Frontieras North America Inc. Puts Mason County at Center of Coal Workforce Revival

Energy security depends on more than pipelines, plants and reserves. It depends on experienced people who know how to run and manage them. Frontieras’s Mason County project is expected to create approximately 200 full-time jobs, with wages averaging three times the average income for the area, along with roughly 2,000 construction jobs during the build phase. The plant itself will process 7,500 tons of coal per day using FASForm(TM), the company's Solid Carbon Fractionation process, producing diesel, naphtha, aviation fuel, hydrogen, methane and FASCarbon(TM), a clean-coal product. A domestic energy project only strengthens the country if it first strengthens the…

Continue Reading

FridaySep 11, 2026 10:30 am

Cheaper Drones Are Exposing a New Weakness in Counter-UAS Defense

The economics of drone warfare are changing rapidly, with inexpensive unmanned systems creating an increasingly difficult cost equation for traditional counter-UAS defenses. At the same time, fiber-optic-guided and autonomous drones can operate without the radio-frequency emissions that many conventional detection and jamming approaches depend on. Wrap Technologies Inc. (NASDAQ: WRAP) is addressing both challenges through WrapShield(TM), combining Frenel Imaging Ltd.’s physics-based sensing technology with laser-directed energy for counter-UAS applications. Drones have become an increasingly important tool in modern military operations, providing intelligence, surveillance and strike capabilities while reducing the need to put personnel directly in harm’s way. As these systems…

Continue Reading

FridaySep 11, 2026 9:45 am

Greenland Mines Ltd. (NASDAQ: GRML) Key Points to Watch Include Rare Earths Closing, Drill Results and Growing AnorTech Stake

Completion of Sarfartoq acquisition announced following formal approval from Greenland government. The 2026 Skaergaard field season is now in its active phase and should generate results before the Arctic season ends. An updated Sarfartoq resource estimate is in progress, and AnorTech stake option is worth tracking closely. Every small-cap mining stock eventually reaches a stretch where several catalysts line up in close succession. That stretch turns a quiet chart into something worth watching closely. For Greenland Mines (NASDAQ: GRML) that stretch is now. Four items are converging: the close of its rare earths acquisition following government approval, the end of…

Continue Reading

FridaySep 11, 2026 9:00 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair

Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring damaged cartilage rather than simply managing the symptoms associated with its loss. Regentis Biomaterials’ GelrinC is designed to support the body’s natural cartilage-regeneration process through a gradual, controlled repair environment. Early clinical data has provided encouraging evidence for GelrinC, which already has approval in Europe, while an FDA-authorized pivotal trial is advancing its development toward potential U.S. approval. A knee that once carried a runner through marathons or a hiker up a steep mountainside can be sidelined by a single defect in cartilage. More broadly,…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000